Last checked at 31 Oct 2017 07:00
Surgical Innovations Group plc
(the "Company")
Grant of Options
The Company announces that on 31 October 2017 options to acquire 31,000,000 ordinary shares of 1p each ("Ordinary Shares") were granted to directors and employees (the "New Options").
The number of New Options granted to directors and PDMRs is as follows:
Director/PDMR | Role | No. of options held previously | New Options granted | Total no. of options held | |
Melanie Ross | COO/CFO | 4,750,000 | 3,000,000 | 7,750,000 | |
Adam Power | Group Development Director | 1,000,000 | 6,000,000 | 7,000,000 | |
David Marsh | Group Commercial Director | 1,000,000 | 6,000,000 | 7,000,000 | |
Michael McMahon | Non-Executive Director | 4,750,000 | 1,750,000 | 6,500,000 | |
Charmaine Day | Company Secretary | 1,500,000 | 1,500,000 | 3,000,000 | |
Nigel Rogers | Chairman | - | 1,750,000 | 1,750,000 | |
All of the New Options are subject to an exercise price of 3.25p per share.
In the case of non-directors, New Options become exercisable on the third anniversary of the date of grant, subject to the individual remaining in the Company's employment at that time, and remain exercisable until the tenth anniversary of the date of grant.
For directors, New Options will only vest subject to the closing price of the Ordinary Shares being at or above one of the following milestones over ten consecutive trading days during the relevant period:
By | Share price (p) |
31-Dec-20 | 5.40 |
31-Dec-21 | 5.81 |
31-Dec-22 | 6.24 |
31-Dec-23 | 6.71 |
31-Dec-24 | 7.21 |
31-Dec-25 | 7.75 |
31-Dec-26 | 8.33 |
31-Dec-27 | 8.96 |
Subject to the New Options granted to directors having vested, they are exercisable between the third and tenth anniversaries of the date of grant.
The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on shares acquired.
For further information please visit www.sigroupplc.com or contact:
Enquiries:
For further information please contact:
Surgical Innovations Group Plc | www.sigroupplc.com |
Nigel Rogers, Executive Chairman | Tel: 0113 230 7597 |
Melanie Ross, COO & CFO |
|
|
|
WH Ireland Limited (NOMAD & Broker) | Tel: 0113 394 6600 |
Tim Feather |
|
Alex Bond |
|
Walbrook PR | Tel: 020 7933 8780 or si@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Melanie Ross | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Operating Officer and Chief Financial Officer, Surgical Innovations Group plc | ||||
b) | Initial notification/ Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Surgical Innovations Group plc | ||||
b) | LEI | 2138004GHGUH3HUZE156 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p
GB0004016704
| ||||
b) | Nature of the transactions | Grant of options | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
N/A N/A | ||||
e) | Date of the transaction | 31 October 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Adam Power | ||||
2 | Reason for the notification | |||||
a) | Position/status | Group Development Director, Surgical Innovations Group plc | ||||
b) | Initial notification/ Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Surgical Innovations Group plc | ||||
b) | LEI | 2138004GHGUH3HUZE156 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p
GB0004016704
| ||||
b) | Nature of the transactions | Grant of options | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
N/A N/A | ||||
e) | Date of the transaction | 31 October 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | David Marsh | ||||
2 | Reason for the notification | |||||
a) | Position/status | Group Commercial Director, Surgical Innovations Group plc | ||||
b) | Initial notification/ Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Surgical Innovations Group plc | ||||
b) | LEI | 2138004GHGUH3HUZE156 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p
GB0004016704
| ||||
b) | Nature of the transactions | Grant of options | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
N/A N/A | ||||
e) | Date of the transaction | 31 October 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Michael McMahon | ||||
2 | Reason for the notification | |||||
a) | Position/status | Non-Executive Director, Surgical Innovations Group plc | ||||
b) | Initial notification/ Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Surgical Innovations Group plc | ||||
b) | LEI | 2138004GHGUH3HUZE156 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p
GB0004016704
| ||||
b) | Nature of the transactions | Grant of options | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
N/A N/A | ||||
e) | Date of the transaction | 31 October 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Charmaine Day | ||||
2 | Reason for the notification | |||||
a) | Position/status | Company Secretary, Surgical Innovations Group plc | ||||
b) | Initial notification/ Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Surgical Innovations Group plc | ||||
b) | LEI | 2138004GHGUH3HUZE156 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p
GB0004016704
| ||||
b) | Nature of the transactions | Grant of options | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
N/A N/A | ||||
e) | Date of the transaction | 31 October 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Nigel Rogers | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chairman, Surgical Innovations Group plc | ||||
b) | Initial notification/ Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Surgical Innovations Group plc | ||||
b) | LEI | 2138004GHGUH3HUZE156 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p
GB0004016704
| ||||
b) | Nature of the transactions | Grant of options | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
N/A N/A | ||||
e) | Date of the transaction | 31 October 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||